“How much is my therapy practice worth?” deserves a better answer than a generic revenue multiple. A useful valuation starts with the earnings another owner can sustain, the risks attached to those earnings, and the terms under which someone will buy the business. Your clinical reputation matters, but it must translate into an operation that can continue.
There is no universal price for an outpatient therapy practice. A clinician acquiring a small office may evaluate the opportunity differently from a regional group adding capacity or an institutional platform acquiring an established management team. A valuation should identify the likely buyer universe and the assumptions behind its range.
The same principle answers “how much is my mental health practice worth?” Define the service mix first. Therapy-only operations, prescribing practices, testing businesses, and intensive treatment programs should not be treated as interchangeable simply because all sit within behavioral health.
For a group practice, begin by examining earnings before interest, taxes, depreciation, and amortization, or EBITDA. Then assess legitimate normalization adjustments. Reported profit may include personal expenses, unusual events, or compensation that differs from what the business would pay an unrelated professional.
A smaller owner-operated practice may be discussed using seller’s discretionary earnings, or SDE, which incorporates the economic benefit to a working owner. SDE and EBITDA are different measures. You cannot compare multiples without understanding which measure is used and what work the purchaser must perform.
List every role you perform: therapy, clinical supervision, recruiting, payer negotiation, scheduling, and general management. Estimate the ongoing cost of replacing the duties you will no longer provide. Include benefits and support costs where relevant, rather than using only a headline salary.
For illustration only, suppose reported EBITDA is $300,000. Removing $180,000 of owner compensation and adding $20,000 of documented nonrecurring costs initially produces $500,000. If replacing the owner’s duties costs $150,000, normalized EBITDA is $350,000. This is an earnings bridge, not a market valuation or a recommended adjustment for your practice.
A buyer needs to understand whether earnings depend on people who intend to leave. Review revenue concentration by clinician, tenure, recruiting capacity, supervision coverage, and the practice’s ability to handle routine decisions without the founder. Those factors shape both value and the transition a buyer may require.
Growing the roster helps only if clinicians can build sustainable caseloads and the practice can support them. Track active capacity, completed visits, and contribution after compensation. Adding headcount shortly before a sale may increase costs before the expected revenue appears.
Evaluate collections by payer and service, the age of receivables, denial patterns, refunds, and the time between care delivery and payment. A practice with growing billed charges can still have weak cash conversion. Explain differences between revenue recognition and cash receipts so buyers do not confuse timing with performance.
Cash-pay and insurance-based models have different exposures. Cash-pay practices should examine referral durability, patient affordability, and pricing history. Insurance-based practices should review contract terms, participation, and reimbursement sensitivity. Neither model deserves an automatic premium without evidence.
Unused rooms, a waiting list, and requests from referring clinicians can support a growth story. They are not earnings already achieved. Estimate the recruiting, supervision, administrative, and marketing costs required to convert that demand into completed and collected visits.
Show a base case built on current operations and a separate growth case with explicit assumptions. Buyers can then distinguish demonstrated performance from an opportunity they must fund and execute. Avoid presenting a full future caseload as if it exists today.
Valuation includes the practicality of operating after close. Maintain current licenses, documented supervision arrangements, payer participation records, and a contract inventory. Ask counsel to assess the proposed transaction structure and any approvals or notices it may require.
For virtual care, document where patients receive services and which clinicians are authorized to treat them. HHS: Licensing across state lines outlines different state pathways. A business plan based on expansion should reflect those actual requirements rather than assuming telehealth removes them.
Enterprise value measures the business under stated assumptions. Equity proceeds depend on debt, cash treatment, working capital, transaction expenses, and other negotiated adjustments. The amount available immediately also depends on escrows, deferred payments, earnouts, and rollover equity.
For illustration only, a $2 million enterprise value less $300,000 of debt and $100,000 of transaction costs leaves $1.6 million before tax, assuming no other adjustments. If $400,000 of that amount is rolled into buyer equity, cash proceeds before tax are $1.2 million. Actual tax outcomes and fund flows require your transaction and tax advisors.
Use more than one perspective. An earnings-based approach examines expected cash generation; market evidence tests whether comparable transactions support the assumptions. Asset value may also matter in a small or distressed practice. The method should fit the business rather than produce the most flattering answer.
Require comparable evidence to match scale, service mix, earnings definition, transaction date, and deal structure. An announced acquisition with no disclosed earnings does not establish an EBITDA multiple. Read what multiple therapy practices sell for before treating a quoted range as a price promise.
Assemble monthly financial statements, tax returns, payroll, an owner-duty summary, collections by payer, clinician-level operating data, and a list of unusual expenses. Reconcile the records and explain changes in services or staffing. Keep patient identifiers out of the initial package.
An advisor should be able to explain which assumptions move the value range and what evidence could narrow it. If the only answer is a multiple applied to revenue, ask how compensation, founder dependence, and the proposed transition were considered.
The best outcome is not simply a number. It is a short list of actions you can influence: stronger billing discipline, reliable monthly reporting, a deeper management team, or a better transition plan. Prioritize actions that improve the practice whether or not a sale happens.
Use Olympic M&A’s behavioral health valuation calculator as an initial conversation starter, then test the assumptions against your records. If “how much is my therapy practice worth?” has become a pressing question, a documented assessment is more useful than applying someone else’s transaction headline.
Start with your numbers using the behavioral health business valuation calculator, then request a confidential consultation to discuss your practice and goals.
Tony Siebel is the Founder and Managing Director of Olympic M&A, a boutique healthcare M&A advisory firm supporting founder-led businesses. His background includes corporate development and independent practice acquisitions at MDVIP, along with experience in behavioral health transactions.
Tony has advised on $70M+ in completed healthcare M&A transactions and was named a Top 50 M&A Advisor in 2025. Through Olympic M&A, he helps owners evaluate their options, prepare for buyer conversations, and navigate the terms and transition of a sale.